Telehealth transplant consults help patients with multiple myeloma overcome racial, age, and rural barriers, speeding eligibility screening and expanding access to specialists.
Related to this article
Benjamin Herzberg, MD, discusses KRAS-mutant non–small cell lung cancer, upfront biomarker testing, and the emerging RAS inhibitor toolkit on Targeted Talks.
Dr Raj Singh previews key ASTRO 2026 data, from FMISO PET-guided de-escalation in HPV-positive head and neck cancer to SRS vs whole brain radiotherapy trials in brain metastases.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Zabilugene Almadenorepvec Plus Chemo Shows Survival Gains in Metastatic PDAC
2
Telehealth May Offer a Path to More Equitable Myeloma Transplant Access
3
Giredestrant Plus Everolimus Improves PFS in ER+ Advanced Breast Cancer
4
In CML, Future Directions Include TKI Sequencing Strategies and Mutational Profiles
5